Quarterly report pursuant to Section 13 or 15(d)

Other Revenue

Other Revenue
3 Months Ended
Mar. 31, 2022
Other revenue [Abstract]  
Other revenue

Note 4 – Other revenue


The Company determined that certain collaborations with a third party are within the scope of ASC 606. The collaboration agreement is made up of multiple modules related to various research activities. The Company identified a single performance obligation to provide research services within each module for which the Company receives monetary consideration. The third party can choose to proceed with each module or can terminate the agreement at any time. The Company recognizes revenue for each module on a straight-line basis over the expected module period. Revenue for succeeding modules is not recognized until all contingencies are resolved, inclusive of the third party’s ability to terminate the module. Other revenue recognized during the three months ended March 31, 2022 and March 31, 2021 was $0.8 million and $0.6 million respectively.


The Company has a grant from a government-sponsored entity for research and development related activities that provide for payments for reimbursed costs, which includes overhead and general and administrative costs as well as an administrative fee. The Company recognizes revenue from grants as it performs services under this arrangement. Associated expenses are recognized when incurred as research and development expense. Other revenue of $0.1 million was recognized for the three months ended March 31, 2022. There was no other revenue recognized from a grant from a government-sponsored entity for the three months ended March 31, 2021.